{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:40:18Z","timestamp":1792600818813,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00246-025-04137-4","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T10:14:35Z","timestamp":1766571275000},"page":"3418-3423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Impact of an Institutional Practice Change from Warfarin to Therapeutic Rivaroxaban Post-Fontan Operation"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-4456","authenticated-orcid":false,"given":"Joel","family":"Livingston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Meakins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Ash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Eckersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"3","key":"4137_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jpeds.2012.03.004","volume":"161","author":"C Manlhiot","year":"2012","unstructured":"Manlhiot C, Brand\u00e3o LR, Kwok J, Kegel S, Menjak IB, Carew CL et al (2012) Thrombotic complications and thromboprophylaxis across all three stages of single ventricle heart palliation. J Pediatr 161(3):513\u2013519e3","journal-title":"J Pediatr"},{"key":"4137_CR2","doi-asserted-by":"publisher","first-page":"803408","DOI":"10.3389\/fped.2022.803408","volume":"10","author":"S Van Den Helm","year":"2022","unstructured":"Van Den Helm S, Sparks CN, Ignjatovic V, Monagle P, Attard C (2022) Increased risk for thromboembolism after Fontan surgery: considerations for thromboprophylaxis. Front Pediatr 10:803408","journal-title":"Front Pediatr"},{"issue":"24","key":"4137_CR3","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","volume":"128","author":"TM Giglia","year":"2013","unstructured":"Giglia TM, Massicotte MP, Tweddell JS, Barst RJ, Bauman M, Erickson CC et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128(24):2622\u20132703","journal-title":"Circulation"},{"issue":"7","key":"4137_CR4","first-page":"1024","volume":"38","author":"JF Heidendael","year":"2022","unstructured":"Heidendael JF, Engele LJ, Bouma BJ, Dipchand AI, Thorne SA, McCrindle BW et al (2022) Coagulation and anticoagulation in Fontan patients. Can J Cardiol 38(7):1024\u20131035","journal-title":"Can J Cardiol"},{"issue":"4","key":"4137_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacc.2022.10.037","volume":"81","author":"J Van den Eynde","year":"2023","unstructured":"Van den Eynde J, Possner M, Alahdab F, Veldtman G, Goldstein BH, Rathod RH et al (2023) Thromboprophylaxis in patients with Fontan circulation. J Am Coll Cardiol 81(4):374\u2013389","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4137_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","volume":"58","author":"P Monagle","year":"2011","unstructured":"Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B et al (2011) A multicenter, randomized trial comparing heparin\/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 58(6):645\u2013651","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4137_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jacc.2012.08.1023","volume":"61","author":"BW McCrindle","year":"2013","unstructured":"McCrindle BW, Manlhiot C, Cochrane A, Roberts R, Hughes M, Szechtman B et al (2013) Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure. J Am Coll Cardiol 61(3):346\u2013353","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4137_CR8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","volume":"7","author":"C Male","year":"2020","unstructured":"Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K et al (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol 7(1):e18\u201327","journal-title":"Lancet Haematol"},{"issue":"22","key":"4137_CR9","doi-asserted-by":"publisher","first-page":"e021765","DOI":"10.1161\/JAHA.120.021765","volume":"10","author":"BW McCrindle","year":"2021","unstructured":"McCrindle BW, Michelson AD, Van Bergen AH, Suzana Horowitz E, Pablo Sandoval J, Justino H et al (2021) Thromboprophylaxis for children Post-Fontan procedure: insights from the UNIVERSE study. J Am Heart Assoc Cardiovasc Cerebrovasc Dis 10(22):e021765","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"6","key":"4137_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00246-022-03094-6","volume":"45","author":"S Duran","year":"2024","unstructured":"Duran S, Gerber C, Bilsky S, Plummer S, Bocks M (2024) Use of Rivaroxaban in children with congenital heart disease: A Single-Center case series. Pediatr Cardiol 45(6):1295\u20131300","journal-title":"Pediatr Cardiol"},{"issue":"24","key":"4137_CR11","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","volume":"82","author":"RM Payne","year":"2023","unstructured":"Payne RM, Burns KM, Glatz AC, Male C, Donti A, Brand\u00e3o LR et al (2023) Apixaban for prevention of thromboembolism in pediatric heart disease. J Am Coll Cardiol 82(24):2296\u20132309","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4137_CR12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.jtha.2023.03.005","volume":"21","author":"C VanderPluym","year":"2023","unstructured":"VanderPluym C, Esteso P, Ankola A, Hellinger A, Ventresco C, Hawkins B et al (2023) Real-world use of Apixaban for the treatment and prevention of thrombosis in children with cardiac disease. J Thromb Haemost JTH 21(6):1601\u20131609","journal-title":"J Thromb Haemost JTH"},{"key":"4137_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12959-018-0185-1","volume":"16","author":"S Willmann","year":"2018","unstructured":"Willmann S, Thelen K, Kubitza D, Lensing AWA, Frede M, Coboeken K et al (2018) Pharmacokinetics of Rivaroxaban in children using physiologically based and population Pharmacokinetic modelling: an EINSTEIN-Jr phase I study. Thromb J 16:32","journal-title":"Thromb J"},{"issue":"2","key":"4137_CR14","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jcph.1966","volume":"62","author":"P Zhu","year":"2022","unstructured":"Zhu P, Willmann S, Zhou W, Yang H, Michelson AD, McCrindle BW et al (2022) Dosing regimen prediction and confirmation with Rivaroxaban for thromboprophylaxis in children after the Fontan procedure: insights from the phase III UNIVERSE study. J Clin Pharmacol 62(2):220\u2013231","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"4137_CR15","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","volume":"21","author":"H Whitworth","year":"2023","unstructured":"Whitworth H, Amankwah EK, Betensky M, Castellucci LA, Cuker A, Goldenberg NA et al (2023) Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost JTH 21(6):1666\u20131673","journal-title":"J Thromb Haemost JTH"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-025-04137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-025-04137-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-025-04137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:53:10Z","timestamp":1792597990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-025-04137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["4137"],"URL":"https:\/\/doi.org\/10.1007\/s00246-025-04137-4","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}